Effectiveness of 13-Valent Pneumococcal Conjugate Vaccine Against Hospitalization for Community-Acquired Pneumonia in Older US Adults: A Test-Negative Design

BACKGROUND: Following universal recommendation for use of 13-valent pneumococcal conjugate vaccine (PCV13) in US adults aged ≥65 years in September 2014, we conducted the first real-world evaluation of PCV13 vaccine effectiveness (VE) against hospitalized vaccine-type community-acquired pneumonia (C...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Clin Infect Dis
Main Authors: McLaughlin, John M, Jiang, Qin, Isturiz, Raul E, Sings, Heather L, Swerdlow, David L, Gessner, Bradford D, Carrico, Ruth M, Peyrani, Paula, Wiemken, Timothy L, Mattingly, William A, Ramirez, Julio A, Jodar, Luis
Formato: Artigo
Idioma:Inglês
Publicado: Oxford University Press 2018
Assuntos:
Articles and Commentaries
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6206101/
https://ncbi.nlm.nih.gov/pubmed/29790925
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciy312
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares